BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yaligar J, Teoh WW, Othman R, Verma SK, Phang BH, Lee SS, Wang WW, Toh HC, Gopalan V, Sabapathy K, Velan SS. Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection. Sci Rep 2016;6:20299. [PMID: 26831370 DOI: 10.1038/srep20299] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Hu Y, Zhou X, Chen L, Li R, Jin S, Liu L, Ju M, Luan C, Chen H, Wang Z, Huang D, Chen K, Zhang J. Landscape of circulating metabolic fingerprinting for keloid. Front Immunol 2022;13:1005366. [DOI: 10.3389/fimmu.2022.1005366] [Reference Citation Analysis]
2 Bogusiewicz J, Burlikowska K, Jaroch K, Gorynska PZ, Gorynski K, Birski M, Furtak J, Paczkowski D, Harat M, Bojko B. Profiling of Carnitine Shuttle System Intermediates in Gliomas Using Solid-Phase Microextraction (SPME). Molecules 2021;26:6112. [PMID: 34684691 DOI: 10.3390/molecules26206112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Hliwa A, Ramos-Molina B, Laski D, Mika A, Sledzinski T. The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update. Int J Mol Sci 2021;22:6900. [PMID: 34199035 DOI: 10.3390/ijms22136900] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
4 Deans JR, Deol P, Titova N, Radi SH, Vuong LM, Evans JR, Pan S, Fahrmann J, Yang J, Hammock BD, Fiehn O, Fekry B, Eckel-mahan K, Sladek FM. HNF4α isoforms regulate the circadian balance between carbohydrate and lipid metabolism in the liver.. [DOI: 10.1101/2021.02.28.433261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sangineto M, Villani R, Cavallone F, Romano A, Loizzi D, Serviddio G. Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma.Cancers (Basel). 2020;12. [PMID: 32486341 DOI: 10.3390/cancers12061419] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 21.5] [Reference Citation Analysis]
6 Ghaffari MH, Sadri H, Schuh K, Dusel G, Prehn C, Adamski J, Koch C, Sauerwein H. Alterations of the acylcarnitine profiles in blood serum and in muscle from periparturient cows with normal or elevated body condition. J Dairy Sci 2020;103:4777-94. [PMID: 32113781 DOI: 10.3168/jds.2019-17713] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hu B, Lin JZ, Yang XB, Sang XT. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review. Cell Prolif 2020;53:e12772. [PMID: 32003505 DOI: 10.1111/cpr.12772] [Cited by in Crossref: 31] [Cited by in F6Publishing: 40] [Article Influence: 15.5] [Reference Citation Analysis]
8 Yoo HJ, Jung KJ, Kim M, Kim M, Kang M, Jee SH, Choi Y, Lee JH. Liver Cirrhosis Patients Who Had Normal Liver Function Before Liver Cirrhosis Development Have the Altered Metabolic Profiles Before the Disease Occurrence Compared to Healthy Controls. Front Physiol 2019;10:1421. [PMID: 31803070 DOI: 10.3389/fphys.2019.01421] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
9 Wu SL, Wei TY, Lin SW, Su KY, Kuo CH. Metabolomics Investigation of Voriconazole-Induced Hepatotoxicity in Mice. Chem Res Toxicol 2019;32:1840-9. [PMID: 31411454 DOI: 10.1021/acs.chemrestox.9b00176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Hu DD, Zhao Q, Cheng Y, Xiao XR, Huang JF, Qu Y, Li X, Tang YM, Bao WM, Yang JH, Jiang T, Hu JP, Gonzalez FJ, Li F. The Protective Roles of PPARα Activation in Triptolide-induced Liver Injury. Toxicol Sci 2019:kfz146. [PMID: 31241159 DOI: 10.1093/toxsci/kfz146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
11 Li S, Gao D, Jiang Y. Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma. Metabolites 2019;9:E36. [PMID: 30795537 DOI: 10.3390/metabo9020036] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 16.0] [Reference Citation Analysis]
12 Nakagawa H, Hayata Y, Kawamura S, Yamada T, Fujiwara N, Koike K. Lipid Metabolic Reprogramming in Hepatocellular Carcinoma. Cancers (Basel) 2018;10:E447. [PMID: 30445800 DOI: 10.3390/cancers10110447] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 17.8] [Reference Citation Analysis]
13 Fujiwara N, Nakagawa H, Enooku K, Kudo Y, Hayata Y, Nakatsuka T, Tanaka Y, Tateishi R, Hikiba Y, Misumi K, Tanaka M, Hayashi A, Shibahara J, Fukayama M, Arita J, Hasegawa K, Hirschfield H, Hoshida Y, Hirata Y, Otsuka M, Tateishi K, Koike K. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity. Gut 2018;67:1493-504. [PMID: 29437870 DOI: 10.1136/gutjnl-2017-315193] [Cited by in Crossref: 66] [Cited by in F6Publishing: 73] [Article Influence: 16.5] [Reference Citation Analysis]
14 Xu Z, Chen T, Luo J, Ding S, Gao S, Zhang J. Cartilaginous Metabolomic Study Reveals Potential Mechanisms of Osteophyte Formation in Osteoarthritis. J Proteome Res 2017;16:1425-35. [PMID: 28166636 DOI: 10.1021/acs.jproteome.6b00676] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
15 Al-Bakheit A, Traka M, Saha S, Mithen R, Melchini A. Accumulation of Palmitoylcarnitine and Its Effect on Pro-Inflammatory Pathways and Calcium Influx in Prostate Cancer. Prostate 2016;76:1326-37. [PMID: 27403764 DOI: 10.1002/pros.23222] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]